MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER Drug Patent Profile
Which patents cover Mannitol 10% W/ Dextrose 5% In Distilled Water, and when can generic versions of Mannitol 10% W/ Dextrose 5% In Distilled Water launch?
Mannitol 10% W/ Dextrose 5% In Distilled Water is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER is mannitol. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the mannitol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER?
- What are the global sales for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER?
- What is Average Wholesale Price for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER?
Summary for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Clinical Trials: | 1 |
| DailyMed Link: | MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER at DailyMed |
Recent Clinical Trials for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Washington University School of Medicine | Phase 4 |
See all MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER clinical trials
US Patents and Regulatory Information for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER | mannitol | INJECTABLE;INJECTION | 016080-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Pharmaxis Europe Limited | Bronchitol | mannitol | EMEA/H/C/001252Bronchitol is indicated for the treatment of cystic fibrosis (CF) in adults aged 18 years and above as an add-on therapy to best standard of care. | Authorised | no | no | no | 2012-04-13 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
